Skip to main content
. 2018 Mar 27;84(1):190–197. doi: 10.1093/neuros/nyy049

TABLE 1.

Patient Characteristics

Categorical variable Categories n (%)
Sex
male 71 (40.6)
female 104 (59.4)
Age
≤60 yr 85(48.6)
>60 yr 90(51.4)
KPS
100 13 (7.4)
90 32 (18.3)
80 51 (29.1)
70 45 (25.7)
other 34 (19.4)
KPS > 70 96(55.8)
KPS ≤ 70 76(44.2)
MGMT promoter methylation status
Methylated 80 (45.7)
Unmethylated 95 (54.3)
Extent of resection
GTR (=100%) 104 (59.4)
STR 71 (40.6)
 ≥95% 49
 ≥90% 58
 ≥80% 66
 ≥75% 69
 <75% 2
Adjuvant therapy
Stupp 94(53.7)
Other 81(46.3)
Continuous variable Median (range)
Age (year) 61 (23-84)
Preoperative tumor volume (cc) 32.1 (1.9-101.9)
Postoperative tumor volume (cc) 0 (0-30.7)
Progression-free survival (day) 266 (8-2225)
Overall survival (day) 466 (8-2225)